These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15457135)

  • 1. Care of very low birth weight infants with respiratory distress syndrome: an evidence-based review.
    Carlo WA; Prince LS; St John EB; Ambalavanan N
    Minerva Pediatr; 2004 Aug; 56(4):373-80. PubMed ID: 15457135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum cortisol levels in a relatively large and mature group of ventilated and nonventilated preterm infants with respiratory distress syndrome.
    Gunes T; Koklu E; Ozturk MA; Koklu S; Cetin N
    Am J Perinatol; 2006 Aug; 23(6):335-9. PubMed ID: 16841278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
    Wirbelauer J; Speer CP
    J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bubble continuous positive airway pressure, a potentially better practice, reduces the use of mechanical ventilation among very low birth weight infants with respiratory distress syndrome.
    Nowadzky T; Pantoja A; Britton JR
    Pediatrics; 2009 Jun; 123(6):1534-40. PubMed ID: 19482765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of mechanical ventilation is associated with rapid activation of circulating phagocytes in preterm infants.
    Turunen R; Nupponen I; Siitonen S; Repo H; Andersson S
    Pediatrics; 2006 Feb; 117(2):448-54. PubMed ID: 16452365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug utilisation in very preterm infants: any changes during the past decade?
    Lindner U; Hilgendorff A; Frey G; Gortner L
    Klin Padiatr; 2008; 220(4):238-42. PubMed ID: 18401813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trials in the treatment of respiratory failure in preterm infants.
    Soll RF
    Neonatology; 2009; 95(4):368-72. PubMed ID: 19494559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of respiratory distress syndrome: an update.
    Rodriguez RJ
    Respir Care; 2003 Mar; 48(3):279-86; discussion 286-7. PubMed ID: 12667277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovations in cardiopulmonary care of the low-birth-weight infant.
    Cusson RM
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1992; 3(1):62-74. PubMed ID: 1562447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plurality-dependent risk of respiratory distress syndrome among very-low-birth-weight infants and antepartum corticosteroid treatment.
    Blickstein I; Shinwell ES; Lusky A; Reichman B;
    Am J Obstet Gynecol; 2005 Feb; 192(2):360-4. PubMed ID: 15695972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary surfactant deficiencies in extremely low birth weight premature infants].
    Rivera S; Gaugler C; Langlet C; Villega F; Astruc D; Escande B; Kuhn P; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1346-50. PubMed ID: 15519835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor in preterm infants with respiratory distress syndrome.
    Tsao PN; Wei SC; Chou HC; Su YN; Chen CY; Hsieh FJ; Hsieh WS
    Pediatr Pulmonol; 2005 May; 39(5):461-5. PubMed ID: 15786439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant replacement therapy for respiratory distress syndrome. American Academy of Pediatrics. Committee on Fetus and Newborn.
    Pediatrics; 1999 Mar; 103(3):684-5. PubMed ID: 10049980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung protective ventilatory strategies in very low birth weight infants.
    Ramanathan R; Sardesai S
    J Perinatol; 2008 May; 28 Suppl 1():S41-6. PubMed ID: 18446177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.
    Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE
    J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of successful extubation of preterm low-birth-weight infants with respiratory distress syndrome.
    Szymankiewicz M; Vidyasagar D; Gadzinowski J
    Pediatr Crit Care Med; 2005 Jan; 6(1):44-9. PubMed ID: 15636658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transthyretin levels are not related to Apgar score in low birth weight and very low birth weight infants.
    Su PH; Wang SL; Chen JY; Hu JM; Chang HP; Chen SJ
    Early Hum Dev; 2008 Aug; 84(8):533-8. PubMed ID: 18252270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.